Audet A M, Anderson F A, St John R
MassPRO, Waltham, MA 02154, USA.
Therapie. 1998 Nov-Dec;53(6):591-4.
The objective of this study was to determine the proportion of Massachusetts Medicare patients who received prophylaxis for venous thromboembolism following colectomy, hysterectomy or total hip arthroplasty. The sample frame was all 90 Massachusetts acute care hospitals, and the time frame was 1 April to 30 September 1994. The patients discharged with an International Classification of Disease (ICD-9-CM) discharge diagnostic code (recorded in the Massachusetts Medicare Claims Database) for colectomy, hysterectomy or total hip arthroplasty were used to identify the target patient population. The sample population comprised 1397 patients randomly selected from the target population, including 467 total hip arthroplasties, 474 colectomies, and 456 hysterectomies. Medical records were reviewed by trained nurse abstractors who collected information on the use of prophylaxis for venous thromboembolism. Prophylaxis for venous thromboembolism was employed by surgeons practicing in Massachusetts hospitals in 93 per cent of total hip arthroplasty cases (regional variation 85-98 per cent), 84 per cent of colectomies (regional variation 57-93 per cent), 66 per cent of hysterectomies (regional variation 35-71 per cent), and in 87 per cent of the subset of 111 hysterectomies with malignancy (regional variation 25-100 per cent). The results of this statewide study demonstrated significant regional and hospital-to-hospital variation in use of prophylaxis for venous thromboembolism following major surgery. A lower rate of prophylaxis use was observed in hospitals with fewer than 200 beds and in hospitals that did not have teaching programmes. Hospitals with below-average rates of prophylaxis were targeted for intensive quality improvement interventions.
本研究的目的是确定马萨诸塞州医疗保险患者在结肠切除术、子宫切除术或全髋关节置换术后接受静脉血栓栓塞预防治疗的比例。样本框架为马萨诸塞州的所有90家急症护理医院,时间框架为1994年4月1日至9月30日。使用国际疾病分类(ICD-9-CM)出院诊断代码(记录在马萨诸塞州医疗保险索赔数据库中)出院的结肠切除术、子宫切除术或全髋关节置换术患者用于确定目标患者群体。样本群体包括从目标人群中随机选取的1397名患者,其中467例行全髋关节置换术,474例行结肠切除术,456例行子宫切除术。经过培训的护士摘要员审查病历,收集有关静脉血栓栓塞预防治疗使用情况的信息。在马萨诸塞州医院执业的外科医生对93%的全髋关节置换术病例(地区差异为85%-98%)、84%的结肠切除术病例(地区差异为57%-93%)、66%的子宫切除术病例(地区差异为35%-71%)以及111例恶性肿瘤子宫切除术亚组中的87%(地区差异为25%-100%)采用了静脉血栓栓塞预防治疗。这项全州范围研究的结果表明,大手术后静脉血栓栓塞预防治疗的使用存在显著的地区和医院间差异。在床位少于200张的医院以及没有教学项目的医院中,预防治疗的使用率较低。预防治疗率低于平均水平的医院被作为强化质量改进干预措施的目标。